TARO-SUMATRIPTAN
TARO PHARMACEUTICALS INC
Quick answers
Is there a shortage of TARO-SUMATRIPTAN in Canada?
No. There is no current shortage of TARO-SUMATRIPTAN 6MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IMITREX
GLAXOSMITHKLINE INC
Other Products
IMITREX INJ 12MG/ML
GLAXO CANADA INC
IMITREX - TAB 50MG
GLAXO CANADA INC
IMITREX TAB 100MG
GLAXO CANADA INC
IMITREX DF - TAB 100MG
GLAXOSMITHKLINE INC
IMITREX DF - TAB 25MG
GLAXOSMITHKLINE INC
DIN
02361698
Strength
6MG
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
See all SUMATRIPTAN (SUMATRIPTAN SUCCINATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TARO PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02247560
DIN 02315033
DIN 02230251
DIN 02304457
0.05% · DIN 00716618
0.1% · DIN 00716626
0.1% · DIN 00716634
0.05% · DIN 00716642
0.1% · DIN 00716650
1% · DIN 00812382
2% · DIN 00812374
1% · DIN 00812366